Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Broadly I think the pharma stocks are likely to do well. So, whether it is Aurobindo Pharma or Sun Pharmaceutical Industries, which is now coming out of a deep correction, both are buying opportunities for the day. It is also important to keep on watching the Nifty, anything below 8,400, do not keep long positions."
At 11:03 hrs Sun Pharmaceutical Industries was quoting at Rs 880.25, up Rs 7.25, or 0.83 percent. It has touched an intraday high of Rs 883.05 and an intraday low of Rs 873.20.
Sun Pharma's trailing 12-month (TTM) EPS was at - per share. (Mar, 2015). The stock's price-to-earnings (P/E) ratio was -. The latest book value of the company is Rs 30.92 per share. At current value, the price-to-book value of the company was 28.49. The dividend yield of the company was 0.17 percent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
